This gene encodes a protein belonging to the RAF family of serine/threonine protein kinases. This protein plays a role in regulating the MAP kinase/ERK signaling pathway, which affects cell division, differentiation, and secretion. Mutations in this gene, most commonly the V600E mutation, are the most frequently identified cancer-causing mutations in melanoma, and have been identified in various other cancers as well, including non-Hodgkin lymphoma, colorectal cancer, thyroid carcinoma, non-small cell lung carcinoma, hairy cell leukemia and adenocarcinoma of lung. Mutations in this gene are also associated with cardiofaciocutaneous, Noonan, and Costello syndromes, which exhibit overlapping phenotypes. A pseudogene of this gene has been identified on the X chromosome.
Applications:
ELISA, WB, IF
Name of antibody:
BRAF (mutated V600A)
Immunogen:
A synthetic peptide from the internal region of human BRAF which includes the mutation of V600A
Full name:
B-Raf proto-oncogene, serine/threonine kinase
Synonyms:
NS7; B-raf; BRAF1; RAFB1; B-RAF1
SwissProt:
P15056
ELISA Recommended dilution:
1000-5000
WB Predicted band size:
84 kDa
WB Positive control:
Purified His-tagged BRAF (mutated V600A) protein
WB Recommended dilution:
500-1000
IF Recommended dilution:
50-100
相关文档
Sample Application
The image is immunofluorescence of HEK293T cells transfected with pCDNA3-GFP-BRAF (WT) plasmid, pCDNA3-GFP-BRAF (mutated V600A) plasmid, pCDNA3-GFP-BRAF (mutated V600D) plasmid, pCDNA3-GFP-BRAF (mutated V600G) plasmid pCDNA3-GFP-BRAF (mutated V600M) plasmid or pCDNA3-GFP-BRAF (mutated V600E) plasmid using D195489(BRAF (mutated V600A) Antibody) at dilution 1/50.